ARTICLE | Product R&D
Local reagent makes good
Genisphere turns old reagents into new nanoparticles, avoids liver
June 2, 2016 7:00 AM UTC
Genisphere LLC is converting its 19 year-old diagnostic reagents into new-age delivery vehicles. The company is repurposing its 3DNA assay technology into nanoparticles that it believes can bring high-valency cargo to target tissues without getting lost in the liver.
Today, Genisphere announced a collaborative research, option to license agreement with MedImmune LLC, the biologics unit of AstraZeneca plc - the biotech's first public deal with a major pharma...